Macquarie Group LTD Adma Biologics, Inc. Transaction History
Macquarie Group LTD
- $80.3 Billion
- Q1 2025
A detailed history of Macquarie Group LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 1,446,390 shares of ADMA stock, worth $28.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,446,390
Previous 1,014,689
42.55%
Holding current value
$28.2 Million
Previous $17.4 Million
64.91%
% of portfolio
0.04%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
379Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$364 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$329 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$251 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$223 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$111 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.83B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...